Trinity Biotech (TRIB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $8.03, +1.26% vs the prior close of $7.93.
- Volume 28.64K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TRIB rises 1.3% to $8.03, a 1-month high, 3 up days in a row. Closed at $8.03, +1.26% vs the prior close of $7.93. Day range $7.37β$8.77, opened at $7.37.
TRIB daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β TRIB rises 1.3% to $8.03, a 1-month high, 3 up days in a row
- Closed at $8.03, +1.26% vs the prior close of $7.93. Day range $7.37β$8.77, opened at $7.37.
- Volume was 28.64K shares, 1.3x its 50-day average of 21.26K.
- Price is -6.9% vs its 50-day average ($8.63) and -50.3% vs its 200-day average ($16.17).
- 52-week range $5.01β$52.50; today's close sits at 6% of that range, 84.7% below the 52-week high.
- That makes 3 straight gains.
Oct 15, 2026 β TRIB jumps 20.0% to $7.93, a 1-month high
- Closed at $7.93, +19.97% vs the prior close of $6.61. Day range $6.21β$8.36, opened at $6.22.
- Volume was 27.40K shares, 1.3x its 50-day average of 20.83K.
- Price is -8.9% vs its 50-day average ($8.70) and -51.2% vs its 200-day average ($16.25).
- 52-week range $5.01β$52.50; today's close sits at 6% of that range, 84.9% below the 52-week high.
Oct 14, 2026 β TRIB jumps 4.9% to $6.61
- Closed at $6.61, +4.92% vs the prior close of $6.30. Day range $6.22β$7.20, opened at $6.82.
- Volume was 10.60K shares, 0.5x its 50-day average of 20.82K β lighter than usual.
- Price is -24.5% vs its 50-day average ($8.76) and -59.5% vs its 200-day average ($16.34).
- 52-week range $5.01β$52.50; today's close sits at 3% of that range, 87.4% below the 52-week high.
Oct 13, 2026 β TRIB slides 4.0% to $6.30
- Closed at $6.30, -3.96% vs the prior close of $6.56. Day range $6.30β$7.51, opened at $7.05.
- Volume was 18.70K shares, 0.9x its 50-day average of 20.58K.
- Price is -28.8% vs its 50-day average ($8.85) and -61.7% vs its 200-day average ($16.45).
- 52-week range $5.01β$52.50; today's close sits at 3% of that range, 88.0% below the 52-week high.
Oct 12, 2026 β TRIB slides 4.4% to $6.56
- Closed at $6.56, -4.37% vs the prior close of $6.86. Day range $6.53β$7.69, opened at $7.09.
- Volume was 23.00K shares, 1.1x its 50-day average of 20.38K.
- Price is -26.6% vs its 50-day average ($8.94) and -60.4% vs its 200-day average ($16.57).
- 52-week range $5.01β$52.50; today's close sits at 3% of that range, 87.5% below the 52-week high.
Oct 9, 2026 β TRIB jumps 13.6% to $6.86
- Closed at $6.86, +13.58% vs the prior close of $6.04. Day range $6.05β$7.23, opened at $6.42.
- Volume was 33.80K shares, 1.7x its 50-day average of 20.48K.
- Price is -24.1% vs its 50-day average ($9.04) and -59.0% vs its 200-day average ($16.73).
- 52-week range $5.01β$52.50; today's close sits at 4% of that range, 86.9% below the 52-week high.
Oct 8, 2026 β TRIB slides 10.5% to $6.04
- Closed at $6.04, -10.52% vs the prior close of $6.75. Day range $5.83β$6.80, opened at $6.70.
- Volume was 12.90K shares, 0.6x its 50-day average of 21.67K β lighter than usual.
- Price is -34.1% vs its 50-day average ($9.16) and -64.1% vs its 200-day average ($16.83).
- 52-week range $5.01β$52.50; today's close sits at 2% of that range, 88.5% below the 52-week high.
Oct 7, 2026 β TRIB slides 5.6% to $6.75
- Closed at $6.75, -5.59% vs the prior close of $7.15. Day range $6.71β$7.16, opened at $7.16.
- Volume was 9.40K shares, 0.4x its 50-day average of 24.13K β lighter than usual.
- Price is -27.5% vs its 50-day average ($9.30) and -60.1% vs its 200-day average ($16.94).
- 52-week range $5.01β$52.50; today's close sits at 4% of that range, 87.1% below the 52-week high.
Oct 6, 2026 β TRIB jumps 23.9% to $7.15
- Closed at $7.15, +23.92% vs the prior close of $5.77. Day range $5.97β$7.34, opened at $6.09.
- Volume was 41.60K shares, 1.8x its 50-day average of 23.57K.
- Price is -24.1% vs its 50-day average ($9.42) and -58.1% vs its 200-day average ($17.05).
- 52-week range $5.01β$52.50; today's close sits at 5% of that range, 86.4% below the 52-week high.
Oct 5, 2026 β TRIB rises 1.4% to $5.77
- Closed at $5.77, +1.41% vs the prior close of $5.69. Day range $5.77β$5.90, opened at $5.77.
- Volume was 3.10K shares, 0.1x its 50-day average of 23.99K β lighter than usual.
- Price is -39.0% vs its 50-day average ($9.46) and -66.4% vs its 200-day average ($17.15).
- 52-week range $5.01β$52.50; today's close sits at 2% of that range, 89.0% below the 52-week high.
- SEC filings that day: 6-K.
Oct 2, 2026 β TRIB slides 10.0% to $5.69, a 52-week low, 8 down days in a row
- Closed at $5.69, -9.97% vs the prior close of $6.32. Day range $5.05β$5.83, opened at $5.70.
- Volume was 12.90K shares, 0.5x its 50-day average of 23.93K β lighter than usual.
- Price is -40.2% vs its 50-day average ($9.51) and -67.0% vs its 200-day average ($17.26).
- 52-week range $5.01β$52.50; today's close sits at 1% of that range, 89.2% below the 52-week high.
- That makes 8 straight losses.
TRIB latest news & SEC filings
Every SEC filing by or about TRIB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 9, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 8, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 1, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Aug 28, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 28, 2026 Β· Form POS AM β POS AM filing
POS AM filing
Aug 21, 2026 Β· Form F-1/A β F-1/A filing
F-1/A filing
Aug 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 14, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 22, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 22, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 2, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 30, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 29, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade TRIB
- How much it moves: over the last 20 sessions the average daily move was 5.86% (largest 23.9%). That is a volatile stock.
- Liquidity: about 14.19K shares (β$113.96K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $8.03 vs a range of $5.01β$52.50 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Jul 24, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 5, 2026; 6-K Sep 9, 2026; 6-K Sep 8, 2026.
- Listing: Nasdaq Β· industry: In Vitro & In Vivo Diagnostic Substances.
TRIB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.37 | 8.77 | 7.37 | 8.03 | 28.64K |
| Oct 15, 2026 | 6.22 | 8.36 | 6.21 | 7.93 | 27.40K |
| Oct 14, 2026 | 6.82 | 7.20 | 6.22 | 6.61 | 10.60K |
| Oct 13, 2026 | 7.05 | 7.51 | 6.30 | 6.30 | 18.70K |
| Oct 12, 2026 | 7.09 | 7.69 | 6.53 | 6.56 | 23.00K |
| Oct 9, 2026 | 6.42 | 7.23 | 6.05 | 6.86 | 33.80K |
| Oct 8, 2026 | 6.70 | 6.80 | 5.83 | 6.04 | 12.90K |
| Oct 7, 2026 | 7.16 | 7.16 | 6.71 | 6.75 | 9.40K |
| Oct 6, 2026 | 6.09 | 7.34 | 5.97 | 7.15 | 41.60K |
| Oct 5, 2026 | 5.77 | 5.90 | 5.77 | 5.77 | 3.10K |
| Oct 2, 2026 | 5.70 | 5.83 | 5.05 | 5.69 | 12.90K |
| Oct 1, 2026 | 6.30 | 6.93 | 5.01 | 6.32 | 16.00K |
| Sep 30, 2026 | 6.32 | 7.14 | 6.32 | 6.43 | 10.20K |
| Sep 29, 2026 | 6.57 | 7.45 | 6.51 | 6.70 | 9.60K |
| Sep 28, 2026 | 6.63 | 7.29 | 6.63 | 6.72 | 2.40K |
| Sep 25, 2026 | 7.33 | 7.33 | 6.62 | 6.76 | 8.20K |
| Sep 24, 2026 | 6.98 | 6.98 | 6.80 | 6.95 | 2.40K |
| Sep 23, 2026 | 7.12 | 7.34 | 6.80 | 7.01 | 3.90K |
| Sep 22, 2026 | 7.32 | 7.40 | 7.32 | 7.40 | 1.90K |
| Sep 21, 2026 | 7.50 | 7.50 | 7.19 | 7.35 | 7.20K |
About Trinity Biotech
Trinity Biotech (TRIB) is listed on the Nasdaq and classified by the SEC under βIn Vitro & In Vivo Diagnostic Substancesβ. Its business address is in WICKLOW. State of incorporation: Ireland. Fiscal year ends December 31. SEC CIK 888721.
TRIB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Gillard | Director | Apr 8, 2026 |
| Ronan O'Caoimh | Director | Apr 8, 2026 |
| Andrew Omidvar | Director | Apr 3, 2026 |
| John Paul Tivnan | Director | Apr 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Murphy | Interim CFO | Apr 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
TRIB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
TRIB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Celldex Therapeutics (CLDX)Intellia Therapeutics (NTLA)Neogen (NEOG)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Q/C Technologies (QCLS)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TRIB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.